Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease

Clinical trial NCT00831467 · COMPLETED

Trial details

NCT number: NCT00831467
Sponsor: CureVac
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hormonal Refractory Prostate Cancer

Start date: 2009-01-01
Primary completion: 2009-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.